(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

DEGRADADORES BIFUNCIONAIS DE QUINASES ASSOCIADAS AO RECEPTOR DE INTERLEUCINA-1 E USO TERAPÊUTICO DOS MESMOS

PublicadaUtility ModelPCT · US2022040765

Application data

Number

122025016760

Type

Utility Model

Filing

08/18/2022

Publication

04/22/2026

PCT

US2022040765

Progress at the INPI

  1. Filing08/18/22
  2. Publication04/22/26
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was published in the RPI gazette on 04/22/2026 and is now open to any interested party. It moves on to technical examination at the INPI.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 04/22/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

GILEAD SCIENCES, INC.

US

NURIX THERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

J. W. (pessoa física)

US

J. L. (pessoa física)

US

K. O. (pessoa física)

US

T. K. (pessoa física)

US

W. P. (pessoa física)

US

Technical data

Priority claims

US

63/234,606 · 08/18/2021

Abstract

DEGRADADORES BIFUNCIONAIS DE QUINASES ASSOCIADAS AO RECEPTOR DE INTERLEUCINA-1 E USO TERAPÊUTICO DOS MESMOS. A presente invenção refere-se a compostos bifuncionais como degradadores de IRAK4 por meio de rota de ubiquitina-proteassoma e método para tratar doenças moduladas por IRAK4.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Publicação do pedido de patente

#3.1

04/22/2026

RPI 2885

Notificação de pedido dividido

#2.4

04/07/2026

RPI 2883

Requerimento de pedido de patente

#2.10

Número de Protocolo '870250070214' em 06/08/2025 20:48 (WB)

08/19/2025

RPI 2850

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.